Lv0
0 积分 2024-11-13 加入
Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results
2天前
已完结
Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial
2天前
已完结
Safety and Efficacy of CT041 in Patients With Refractory Metastatic Pancreatic Cancer: A Pooled Analysis of Two Early-Phase Trials
2天前
已完结
Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastoma
2天前
已完结
Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers
3天前
已完结
Anti–CD19 CAR T Cells in Refractory Immune Thrombocytopenia of SLE
3天前
已完结
CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn
24天前
已完结
CD19/CD22 Dual-Targeted CAR T-cell Therapy for Relapsed/Refractory Aggressive B-cell Lymphoma: A Safety and Efficacy Study
1个月前
已完结
Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 study
1个月前
已完结
Anti-BCMA/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trial
1个月前
已完结
皖公网安备34019202002308
